Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience.
Ann Rheum Dis
; 81(10): e188, 2022 10.
Article
in English
| MEDLINE | ID: covidwho-698881
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Physicians
/
Rheumatology
/
Rheumatic Diseases
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Ann Rheum Dis
Year:
2022
Document Type:
Article
Affiliation country:
Annrheumdis-2020-218528
Similar
MEDLINE
...
LILACS
LIS